Lianjun Xu

677 total citations
41 papers, 404 citations indexed

About

Lianjun Xu is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lianjun Xu has authored 41 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 19 papers in Surgery and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lianjun Xu's work include Cardiac Imaging and Diagnostics (15 papers), Acute Myocardial Infarction Research (14 papers) and Coronary Interventions and Diagnostics (13 papers). Lianjun Xu is often cited by papers focused on Cardiac Imaging and Diagnostics (15 papers), Acute Myocardial Infarction Research (14 papers) and Coronary Interventions and Diagnostics (13 papers). Lianjun Xu collaborates with scholars based in China, United States and South Africa. Lianjun Xu's co-authors include Rutai Hui, Jinqing Yuan, Lei Song, Xueyan Zhao, Kai Sun, Lin Jiang, Jian Tian, Xinxing Feng, Wei Zhao and Ce Zhang and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and European Heart Journal.

In The Last Decade

Lianjun Xu

36 papers receiving 400 citations

Peers

Lianjun Xu

CCM

SURGE

PRM

EDM

RNMI

Hongya Han China

Yoichi Iwasaki Japan

Selahattin Aydın Türkiye

Kumeo Ono Japan

Michele Mattia Viscusi Italy

Ryo Kameda Japan

Pei Zhu China

Amira Zaroui France

Hiroyuki Omori Japan

Necip Ermiş Türkiye

Hongya Han China

Lianjun Xu

271 ×1.5

CCM

181 ×1.1

SURGE

108 ×0.9

PRM

103 ×1.6

EDM

65 ×1.2

RNMI

Citations per year, relative to Lianjun Xu Lianjun Xu (= 1×) peers Hongya Han

Countries citing papers authored by Lianjun Xu

Since Specialization

Citations

This map shows the geographic impact of Lianjun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianjun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianjun Xu more than expected).

Fields of papers citing papers by Lianjun Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianjun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianjun Xu. The network helps show where Lianjun Xu may publish in the future.

Co-authorship network of co-authors of Lianjun Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lianjun Xu. A scholar is included among the top collaborators of Lianjun Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianjun Xu. Lianjun Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yu, Channa Zhang, Lianjun Xu, et al.. (2025). Assessment of Right Atrial Strain by Echocardiography for Predicting Prognosis in Hypertrophic Cardiomyopathy. JACC Asia. 5(8). 1078–1081.

Li, Jiawen, Lin Jiang, Lianjun Xu, et al.. (2024). Long-Term Outcomes of Sex Differences in Three-Vessel Coronary Disease with Different Treatment Strategies: A Large Cohort Study. Global Heart. 19(1). 57–57.

Zhang, Yu, Ce Zhang, Lin Jiang, et al.. (2023). An elevated triglyceride-glucose index predicts adverse outcomes and interacts with the treatment strategy in patients with three-vessel disease. Cardiovascular Diabetology. 22(1). 333–333. 11 indexed citations

Yuan, Deshan, Tianyu Li, Lin Jiang, et al.. (2023). Mild Renal Function Impairment and Long-Term Outcomes in Patients with Three-Vessel Coronary Artery Disease: A Cohort Study. Cardiorenal Medicine. 13(1). 354–362.

Zhang, Yu, Dong Wang, Lianjun Xu, et al.. (2023). Cardiac index: A superior parameter of cardiac function than left ventricular ejection fraction in risk stratification of hypertrophic cardiomyopathy. Heart Rhythm. 20(7). 958–967. 1 indexed citations

Feng, Xinxing, Ce Zhang, Junhao Liu, et al.. (2023). Machine learning improves mortality prediction in three-vessel disease. Atherosclerosis. 367. 1–7. 6 indexed citations

Li, Jiawen, Xiaofang Tang, Jingjing Xu, et al.. (2023). HMGCR gene polymorphism is associated with residual cholesterol risk in premature triple-vessel disease patients treated with moderate-intensity statins. BMC Cardiovascular Disorders. 23(1). 317–317. 2 indexed citations

Liu, Jie, Dong Wang, Lianjun Xu, et al.. (2022). Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy. BMC Medicine. 20(1). 21–21. 10 indexed citations

Jiang, Lin, Lianjun Xu, Jian Tian, et al.. (2022). Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel Disease. Frontiers in Cardiovascular Medicine. 9. 879834–879834. 1 indexed citations

10.

Zhao, Xueyan, Lianjun Xu, Lin Jiang, et al.. (2021). Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China. Cardiovascular Diabetology. 20(1). 16–16. 6 indexed citations

11.

Liu, Yue, Ce Zhang, Lin Jiang, et al.. (2021). Direct Bilirubin Levels Predict Long-Term Outcomes in Patients With Acute Coronary Syndrome Under Different Glucose Metabolism Status: A 6.5-Year Cohort Study of Three-Vessel Disease. Frontiers in Cardiovascular Medicine. 8. 715539–715539. 2 indexed citations

12.

Zhao, Xueyan, Jiawen Li, Xiaofang Tang, et al.. (2020). Association of NPC1L1 and HMGCR Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel Disease. Human Gene Therapy. 32(11-12). 581–588. 5 indexed citations

13.

Feng, Xinxing, Ce Zhang, Lin Jiang, et al.. (2020). Body mass index and mortality in patients with severe coronary artery diseases: A cohort study from China. Nutrition Metabolism and Cardiovascular Diseases. 31(2). 448–454. 8 indexed citations

14.

Yuan, Deshan, Ce Zhang, Sida Jia, et al.. (2020). Predictive value of free triiodothyronine (FT3) to free thyroxine (FT4) ratio in long-term outcomes of euthyroid patients with three-vessel coronary artery disease. Nutrition Metabolism and Cardiovascular Diseases. 31(2). 579–586. 25 indexed citations

15.

Jiang, Lin, Lianjun Xu, Jian Tian, et al.. (2019). Impact of Lipoprotein(a) on Long-Term (Mean 6.2 Years) Outcomes in Patients With Three-Vessel Coronary Artery Disease. The American Journal of Cardiology. 125(4). 528–533. 10 indexed citations

16.

Zhao, Xueyan, Jianxin Li, Xiaofang Tang, et al.. (2018). Evaluation of CRUSADE and ACUITY-HORIZONS Scores for Predicting Long-term Out-of-Hospital Bleeding after Percutaneous Coronary Interventions. Chinese Medical Journal. 131(3). 262–267. 3 indexed citations

17.

Xu, Jingjing, Yin Zhang, Lin Jiang, et al.. (2018). Comparison of Long-term Outcomes in Patients with Premature Triple-vessel Coronary Disease Undergoing Three Different Treatment Strategies. Chinese Medical Journal. 131(1). 1–9. 3 indexed citations

18.

Zhang, Ce, Lin Jiang, Lianjun Xu, et al.. (2018). Implications of Hyperuricemia in Severe Coronary Artery Disease. The American Journal of Cardiology. 123(4). 558–564. 16 indexed citations

19.

Wu, Chao, Hong Qiu, Lianjun Xu, et al.. (2013). Inhibitory effect of iron on in vitro proliferation of smooth muscle cells. Chinese Medical Journal. 126(19). 3728–3731. 2 indexed citations

20.

Paulson, Thomas G., Patricia C. Galipeau, Lianjun Xu, et al.. (2008). p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus. PLoS ONE. 3(11). e3809–e3809. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact